We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Burke & Herbert Financial Services Corp
BHRB
$1.47B
| $209K | ﹤0.01% |
+3,315
| New | +$165K |
|
2202
SelectQuote
SLQT
$123M
| $207K | ﹤0.01% |
151,259
+52,269
| +53% | +$68.2K |
|
2203
Hingham Institution for Saving
HIFS
$657M
| $207K | ﹤0.01% |
+1,064
| New | +$182K |
|
|
PRFT
2204
DELISTED
Perficient Inc
PRFT
| $207K | ﹤0.01% |
3,140
-692
| -18% | -$42.6K |
|
2205
Vir Biotechnology
VIR
$1.5B
| $206K | ﹤0.01% |
20,493
-69,382
| -77% | -$634K |
|
|
DAY
2206
DELISTED
Dayforce
DAY
| $206K | ﹤0.01% |
3,068
-4,468
| -59% | -$305K |
|
2207
OneWater Marine
ONEW
$205M
| $205K | ﹤0.01% |
6,074
-2,645
| -30% | -$69.9K |
|
2208
LGI Homes
LGIH
$1.32B
| $205K | ﹤0.01% |
+1,541
| New | +$171K |
|
2209
Vericel Corp
VCEL
$2.25B
| $205K | ﹤0.01% |
5,762
-2,484
| -30% | -$86.5K |
|
2210
Fidelity MSCI Real Estate Index ETF
FREL
$1.47B
| $205K | ﹤0.01% |
+7,684
| New | +$183K |
|
2211
XP
XP
$8.37B
| $204K | ﹤0.01% |
+7,843
| New | +$179K |
|
|
ASAI
2212
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $203K | ﹤0.01% |
14,724
-3,828
| -21% | -$47.7K |
|
|
SEM
2213
DELISTED
Select Medical
SEM
| $203K | ﹤0.01% |
16,008
-20,225
| -56% | -$255K |
|
2214
Bridgewater Bancshares
BWB
$598M
| $201K | ﹤0.01% |
14,900
-56,428
| -79% | -$594K |
|
2215
Seneca Foods Class A
SENEA
$1.22B
| $201K | ﹤0.01% |
3,841
-4,205
| -52% | -$220K |
|
2216
Globalstar
GSAT
$10.9B
| $200K | ﹤0.01% |
6,879
+3,369
| +96% | +$74.1K |
|
2217
Navitas Semiconductor
NVTS
$3.44B
| $199K | ﹤0.01% |
24,686
-4,372
| -15% | -$29.3K |
|
2218
Applied Digital
APLD
$8.37B
| $198K | ﹤0.01% |
29,444
-789
| -3% | -$4.24K |
|
2219
Motorcar Parts of America
MPAA
$235M
| $197K | ﹤0.01% |
21,107
-163,718
| -89% | -$1.38M |
|
2220
MiMedx Group
MDXG
$622M
| $196K | ﹤0.01% |
22,318
+428
| +2% | +$3.13K |
|
|
INZY
2221
DELISTED
Inozyme Pharma
INZY
| $196K | ﹤0.01% |
45,913
+26,169
| +133% | +$93K |
|
2222
Adaptive Biotechnologies
ADPT
$4.05B
| $194K | ﹤0.01% |
39,525
+26,313
| +199% | +$120K |
|
2223
Aurinia Pharmaceuticals
AUPH
$2.06B
| $193K | ﹤0.01% |
21,435
+2,829
| +15% | +$23.3K |
|
|
BORR
2224
Borr Drilling
BORR
$1.28B
| $192K | ﹤0.01% |
26,102
-3,738
| -13% | -$24.6K |
|
2225
The GEO Group
GEO
$4.04B
| $190K | ﹤0.01% |
17,539
+4,028
| +30% | +$38.5K |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.